Safety Measures Of L-carnitine L-tartrate Supplementation In Healthy Men
| Effect | None |
| Values | (10³ mm³) Mean and SE. Placebo: 0.07 (0.01) Carnitine: 0.07 (0.01) |
| Trial Design | Randomized trial |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 10 |
| Sex | Male |
In a randomized, double-blind, placebo-controlled cross-over trial 10 healthy, active participants took 3 g of L-carnitine-L-tartrate daily for 3 weeks or placebo before crossing over to the other condition.
There were no statistically significant differences for: blood urea nitrogen, uric acid, creatinine, liver enzymes, bilirubin, protein, albumin, electrolytes, or blood cells.
